首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   911381篇
  免费   64248篇
  国内免费   2419篇
耳鼻咽喉   12626篇
儿科学   28973篇
妇产科学   26476篇
基础医学   128348篇
口腔科学   24987篇
临床医学   76040篇
内科学   185801篇
皮肤病学   19491篇
神经病学   72179篇
特种医学   37069篇
外国民族医学   336篇
外科学   144177篇
综合类   19174篇
现状与发展   1篇
一般理论   249篇
预防医学   65092篇
眼科学   20335篇
药学   64797篇
中国医学   1940篇
肿瘤学   49957篇
  2018年   9447篇
  2017年   7450篇
  2016年   8011篇
  2015年   9149篇
  2014年   12989篇
  2013年   19838篇
  2012年   26669篇
  2011年   28242篇
  2010年   17151篇
  2009年   16246篇
  2008年   26899篇
  2007年   28487篇
  2006年   28615篇
  2005年   28143篇
  2004年   26896篇
  2003年   25956篇
  2002年   25519篇
  2001年   41701篇
  2000年   42871篇
  1999年   36513篇
  1998年   10076篇
  1997年   9234篇
  1996年   9160篇
  1995年   8505篇
  1994年   8132篇
  1993年   7617篇
  1992年   28288篇
  1991年   27058篇
  1990年   26499篇
  1989年   25399篇
  1988年   23603篇
  1987年   23229篇
  1986年   22299篇
  1985年   21197篇
  1984年   15837篇
  1983年   13496篇
  1982年   8099篇
  1979年   14618篇
  1978年   10223篇
  1977年   8656篇
  1976年   8170篇
  1975年   8984篇
  1974年   10723篇
  1973年   10207篇
  1972年   9687篇
  1971年   8932篇
  1970年   8606篇
  1969年   8047篇
  1968年   7705篇
  1967年   7100篇
排序方式: 共有10000条查询结果,搜索用时 17 毫秒
61.
Farnesyltransferase (FTase) is one of the prenyltransferase family enzymes that catalyse the transfer of 15-membered isoprenoid (farnesyl) moiety to the cysteine of CAAX motif-containing proteins including Rho and Ras family of G proteins. Inhibitors of FTase act as drugs for cancer, malaria, progeria and other diseases. In the present investigation, we have developed two structure-based pharmacophore models from protein–ligand complex (3E33 and 3E37) obtained from the protein data bank. Molecular dynamics (MD) simulations were performed on the complexes, and different conformers of the same complex were generated. These conformers were undergone protein–ligand interaction fingerprint (PLIF) analysis, and the fingerprint bits have been used for structure-based pharmacophore model development. The PLIF results showed that Lys164, Tyr166, TrpB106 and TyrB361 are the major interacting residues in both the complexes. The RMSD and RMSF analyses on the MD-simulated systems showed that the absence of FPP in the complex 3E37 has significant effect in the conformational changes of the ligands. During this conformational change, some interactions between the protein and the ligands are lost, but regained after some simulations (after 2 ns). The structure-based pharmacophore models showed that the hydrophobic and acceptor contours are predominantly present in the models. The pharmacophore models were validated using reference compounds, which significantly identified as HITs with smaller RMSD values. The developed structure-based pharmacophore models are significant, and the methodology used in this study is novel from the existing methods (the original X-ray crystallographic coordination of the ligands is used for the model building). In our study, along with the original coordination of the ligand, different conformers of the same complex (protein–ligand) are used. It concluded that the developed methodology is significant for the virtual screening of novel molecules on different targets.  相似文献   
62.
63.

Background

Arterial vascular anomalies in patients undergoing kidney transplantation (KT) are correlated with a higher incidence of early surgical complications, potentially causing graft loss. Arterial reconstruction allows patients to overcome these surgical challenges, thus minimizing the risk of poor outcomes. The aim of the present study is to retrospectively investigate the safety and effectiveness of the multiple arterial reconstruction technique with a Teflon patch in case of an unavailable aortic patch: to do so, surgical complications, graft function, and patient survival were evaluated.

Methods

During the period January 2009 to August 2016, 202 adult deceased-donor KTs were performed at our center. Group A (n = 27; reconstruction of multiple arteries) and Group B (n = 175; control group) were compared.

Results

No differences were observed between the 2 groups in terms of early postoperative course, with no vascular complication observed in Group A. No vascular patch infections were reported, nor longer cold ischemia time rates. Similarly, long-term survival rates were similar between the 2 groups.

Conclusions

The Teflon-patch arterial reconstruction technique appears to be safe and effective, with an acceptable balance of benefits and potential risks of using a prosthetic material. Studies based on larger series are needed to further validate this approach.  相似文献   
64.
65.
66.
Demodex mites are microscopic arachnids found in the normal skin of many mammals. In humans, it is well established that Demodex mite density is higher in patients with the skin condition rosacea, and treatment with acaricidal agents is effective in resolving symptoms. However, pathophysiology of rosacea is complex and multifactorial. In dogs, demodicosis is a significant veterinary issue, particularly the generalized form of the disease which can be fatal if untreated. In each species, clinical and molecular studies have shown that the host’s immunological interactions with Demodex mites are an important, but not fully understood, aspect of how Demodex can live in the skin either as a harmless commensal organism or as a pathogenic agent. This review outlines the role of Demodex mites in humans and dogs, considering morphology, prevalence, symptoms, diagnosis, histology treatment and pathogenesis.  相似文献   
67.
68.
目的:探讨甲状旁腺激素(PTH)对大鼠牵张成骨(DO)过程中ONC、OPN、C-FOS、COL1、VEGF、RUNX2、ALP基因表达的影响。方法30只雄性大鼠制备大鼠下颌骨DO模型。随机分5组,每组6只。第1组(只有牵张无PTH),术后8周取材,应用HE染色及微CT检测,以确定成骨情况。第2组(有牵张无PTH),第3组(有牵张有PTH),第4组(无牵张有PTH),第5组(对照组:无牵张无PTH)。2、3、4组及对照组术后1周取材,RT-PCR测定ONC、OPN、C-FOS、COL1、VEGF、RUNX2、ALP基因的表达。结果第1组,新骨形成,骨质充满牵张区,骨质连续,大鼠建模成功。RT-PCR检测结果显示,2、3、4组与对照组比较,OPN、COL1、RUNX2、ALP基因表达有明显提高(P<0.05),其中第3组最为明显。ONC、C-FOS、VEGF基因2、3、4组与对照组比较差异无统计学意义(P>0.05)。结论 PTH在 DO 过程中,间歇性给以 PTH的作用只有在牵张期发挥作用,其对 OPN、COL1、RUNX2、ALP基因表达能够获得理想的协同作用。  相似文献   
69.
70.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号